<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Site da Brakke Consulting</provider_name><provider_url>https://brakkeconsulting.com/pt</provider_url><title>News from Brakke Consulting</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="2fkAgQhyfV"&gt;&lt;a href="https://brakkeconsulting.com/pt/20033/"&gt;Not&#xED;cias e notas sobre sa&#xFA;de animal de 9 de janeiro de 2004&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://brakkeconsulting.com/pt/20033/embed/#?secret=2fkAgQhyfV" width="600" height="338" title="&#x201C;Not&#xED;cias e notas sobre sa&#xFA;de animal para 9 de janeiro de 2004&#x201D; &#x2014; Site da Brakke Consulting" data-secret="2fkAgQhyfV" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://brakkeconsulting.com/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;</html><description>printer friendly version ******************************************************************* &nbsp;Brakke Consulting&rsquo;s &nbsp;Animal Health News &amp; Notes for January 9, 2004 &nbsp;Copyright &copy; Brakke Consulting, Inc. &nbsp;******************************************************************* IN THE NEWS: &nbsp; other news: Advanced ID Central Garden &amp; Pet Daiichi eMerge Interactive IAMS Kent Marine Land O&rsquo;Lakes Meiji Seika Merial Novartis Phibro Animal Health PPL Therapeutics Virbac &nbsp; ******************************************************************** COMPANY NEWS RELEASES &nbsp; &gt;&nbsp;&nbsp; Virbac Corporation announced the introduction of Clintabs (clindamycin hydrochloride) Tablets, the first veterinary clindamycin tablet formulation for dogs in the US.&nbsp; Until now, clindamycin was available only as a liquid. Clintabs are available in 25mg, 75mg and 150mg tablet presentations and are used to treat infections of the oral cavity, skin, and bone. In addition to the tablets, Virbac is also introducing Clinsol (clindamycin hydrochloride) Liquid, a liquid formulation of clindamycin for use in dogs and cats. (Business Wire)&nbsp;&nbsp;&nbsp; &nbsp; &gt;&nbsp; Central Garden &amp; Pet Company announced that it has acquired substantially all of the assets of Kent Marine, Inc.&nbsp; Kent Marine markets and sells premium aquarium supplies domestically and internationally . Kent Marine is a leading supplier of saltwater aquarium supplements and conditioners with annual sales of approximately $7 million. Terms were not disclosed. (Business Wire) &nbsp; &gt;&nbsp; Merial announced the release of a new equine vaccine: RECOMBITEK Equine West Nile Virus (WNV) vaccine. The&nbsp; USDA recently approved RECOMBITEK Equine WestView Full Post;</description></oembed>
